Correlation Between Salesforce and Revolution Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Revolution Medicines, you can compare the effects of market volatilities on Salesforce and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Revolution Medicines.

Diversification Opportunities for Salesforce and Revolution Medicines

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Salesforce and Revolution is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Salesforce i.e., Salesforce and Revolution Medicines go up and down completely randomly.

Pair Corralation between Salesforce and Revolution Medicines

Considering the 90-day investment horizon Salesforce is expected to generate 0.49 times more return on investment than Revolution Medicines. However, Salesforce is 2.04 times less risky than Revolution Medicines. It trades about -0.15 of its potential returns per unit of risk. Revolution Medicines is currently generating about -0.14 per unit of risk. If you would invest  33,623  in Salesforce on October 20, 2024 and sell it today you would lose (1,167) from holding Salesforce or give up 3.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  Revolution Medicines

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Revolution Medicines 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Revolution Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Salesforce and Revolution Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Revolution Medicines

The main advantage of trading using opposite Salesforce and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.
The idea behind Salesforce and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules